We've found
184,457
clinical trials
We've found
184,457
clinical trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Unlock the Cell: Castleman's Disease Flow Cytometry Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Lymphoma Clinical Trial
Updated: 12/31/1969
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Pancreatic Cancer Clinical Trial
Updated: 4/23/2018
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials

Pancreatic Cancer Clinical Trial
Updated: 4/23/2018
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials

Restless Legs Syndrome (RLS) Clinical Trial
Updated: 12/31/1969
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Other, Reproductive Clinical Trial
Updated: 12/31/1969
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Premature Birth Clinical Trial
Updated: 12/31/1969
A Smart, "Always -On" Health Monitoring System
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Urinary Bladder Neoplasms Clinical Trial
Updated: 8/16/2016
The Bladder Instillation Comparison Study
Status: Enrolling,
Phase
III
Updated: 8/16/2016
Click here to add this to my saved trials

Adenomyosis Clinical Trial
Updated: 8/16/2016
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling,
Phase
II
Updated: 8/16/2016
Click here to add this to my saved trials

Smoking Cessation Clinical Trial
Updated: 12/31/1969
Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Bipolar Depression Clinical Trial
Updated: 12/23/2015
Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
Status: Enrolling,
Phase
III
Updated: 12/23/2015
Click here to add this to my saved trials

Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Sigmoid Diseases Clinical Trial
Updated: 2/22/2016
Robotic-assisted Versus Laparoscopic Sigmoid Resection
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials

Respiratory Distress Syndrome Clinical Trial
Updated: 12/28/2015
Trial to Assess the Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
Status: Enrolling,
Phase
II
Updated: 12/28/2015
Click here to add this to my saved trials

Respiratory Distress Syndrome Clinical Trial
Updated: 12/28/2015
Trial to Assess the Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
Status: Enrolling,
Phase
II
Updated: 12/28/2015
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumors Harbouring NTRK Fusion Clinical Trial
Updated: 12/31/1969
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumors Harbouring NTRK Fusion Clinical Trial
Updated: 12/31/1969
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Post-Traumatic Stress Disorder Clinical Trial
Updated: 12/31/1969
Vortioxetine for Posttraumatic Stress Disorder
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Clinical Trial
Updated: 12/31/1969
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Sarcopenia Clinical Trial
Updated: 10/11/2017
Role of MicroRNAs on Age and Contraction-induced Skeletal Muscle Growth
Status: Enrolling
Updated: 10/11/2017
Click here to add this to my saved trials

Alcohol Drinking Clinical Trial
Updated: 12/31/1969
Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology, Other Clinical Trial
Updated: 12/31/1969
Tumor Related Epilepsy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumors Clinical Trial
Updated: 12/31/1969
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumors Clinical Trial
Updated: 12/31/1969
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumors Clinical Trial
Updated: 12/31/1969
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumors Clinical Trial
Updated: 12/31/1969
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

HEAD AND NECK CANCER Clinical Trial
Updated: 12/31/1969
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HEAD AND NECK CANCER Clinical Trial
Updated: 12/31/1969
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Post-ERCP Acute Pancreatitis Clinical Trial
Updated: 6/10/2016
Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
Status: Enrolling,
Phase
III
Updated: 6/10/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 3/28/2018
Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
